Public HealthOptimizing HCV treatment – Moving beyond the cost conundrum
References (41)
The changing epidemiology of hepatitis C virus infection in the United States: National Health and Nutrition Examination Survey 2001 through 2010
J Hepatol
(2014)Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease
Gastroenterology
(2009)- et al.
Projecting future complications of chronic hepatitis C in the United States
Liver Transpl
(2003) - et al.
Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States
Dig Liver Dis
(2011) - et al.
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial
Lancet
(2001) Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010
Ann Intern Med
(2014)- Centers for Disease Control and Prevention. Viral hepatitis: hepatitis C FAQs for health professionals [Internet]....
- CMS.gov. Decision memo for screening for hepatitis C virus (HCV) in adults (CAG-00436N) [Internet]. Baltimore (MD):...
- et al.
Incidence of acute hepatitis C virus infection among men who have sex with men with and without HIV infection: a systematic review
Sex Transm Infect
(2012) - et al.
Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006–2012
Clin Infect Dis
(2014)
The global burden of hepatitis C
Liver Int
Evolving epidemiology of hepatitis C virus in the United States
Clin Infect Dis
Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001–2008
Hepatology
Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965
MMWR Recomm Rep
The natural history of hepatitis C virus (HCV) infection
Int J Med Sci
The history of the “natural history” of hepatitis C (1968–2009)
Liver Int
Effect of hepatitis C virus and its treatment on survival
Hepatology
Risk factors for the rising rates of primary liver cancer in the United Stats
Arch Intern Med
Chronic hepatitic C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study
JID
Cited by (8)
Updated Pathway to Micro-elimination of Hepatitis C Virus in the Hemodialysis Population
2021, Kidney International ReportsCitation Excerpt :HCV-RNA polymerase chain reaction detection in dialysate may reflect viral RNA fragments, rather than the infectious virus.18 Some individuals could be members of more than 1 at-risk subpopulation at the time of starting dialysis.2,46,47 The cornerstone of HD facility transmission control is process safety, which includes the following: (i) the accurate and early identification of the HCV-infected reservoir using regularly scheduled HCV-RNA screening; (ii) the implementation and optimization of bedside HD safety processes via peer- and HD facility−driven leadership and public health and regional oversight; and (iii) capitalizing on technological support opportunities (Figure 2).
DOT-C: A cluster randomised feasibility trial evaluating directly observed anti-HCV therapy in a population receiving opioid substitute therapy from community pharmacy
2017, International Journal of Drug PolicyCitation Excerpt :People who inject drugs may find it difficult to consistently attend the medical clinics that are the mainstay of standard of care (Papatheodoridis et al., 2014). Delaying treatment because of funding problems risks patients being lost to follow-up (Fox & McCombs, 2016). Creating the complex interventions necessary to eliminate HCV requires that well-designed cross-disciplinary programmes are put in place (Suther & Harries, 2016) using a variety of strategies to increase screening, testing and diagnosis (Brouard et al., 2015).
Age-dependent optimal policies for hepatitis C virus treatment
2021, International Transactions in Operational ResearchTreatment of early stage chronic hepatitis C virus infection
2018, Expert Review of Clinical Pharmacology